Aliskiren/amlodipine/hydrochlorothiazide
From Infogalactic: the planetary knowledge core
| Combination of | |
|---|---|
| Aliskiren | Renin inhibitor |
| Amlodipine | Calcium channel blocker |
| Hydrochlorothiazide | Diuretic |
| Clinical data | |
| AHFS/Drugs.com | Consumer Drug Information |
| Licence data | US FDA:link |
| Pregnancy category |
|
| Legal status |
|
| Routes of administration |
Oral |
| Identifiers | |
| CAS Number | 1486517-17-2 |
| ATC code | C09XA54 (WHO) |
| (verify) | |
The drug combination aliskiren/amlodipine/hydrochlorothiazide (INNs, trade name Amturnide) is an antihypertensive approved by the U.S. Food and Drug Administration (FDA) on December 21, 2010.[1]
References
External links
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
